Neogen amends 8-K to add shareholder approval of incentive plan
Neogen Corporation filed an amended report to disclose that shareholders approved an updated omnibus equity incentive plan at the company's October 1, 2026 annual meeting.
Neogen Corporation filed a Form 8-K/A on October 26, 2026 updating an original Form 8-K filed October 7, 2026. The amendment adds disclosure under Item 5.02 covering shareholder approval of the company's Amended and Restated Omnibus Incentive Plan.1 Apart from that addition, the amendment does not change or update the rest of the original filing, and it does not cover anything that happened after that original filing.1
At Neogen's annual shareholder meeting on October 1, 2026, shareholders voted to approve the Amended and Restated Omnibus Incentive Plan.1 The plan updates and replaces the company's prior 2023 Omnibus Incentive Plan, which shareholders had approved earlier.1
Under the plan, Neogen can issue several types of equity compensation, including options to buy stock, rights tied to stock price gains, restricted shares and share units, and units linked to performance targets, among other stock-based awards. Both non-employee board members and company or subsidiary employees, including named executive officers, are eligible to receive awards.1 The plan caps total shares issuable at 31,350,000, subject to possible adjustments.1
Full details of the plan were included in Neogen's proxy statement filed with the SEC on August 21, 2026, where the plan text was attached as Appendix A.1 The amended filing also attaches the plan document as an exhibit and includes a standard cover page data file. The report was signed by Chief Financial Officer R. Bryan Riggsbee.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.